Int. J. Mol. Sci. 2012, 13(8), 9741-9753; doi:10.3390/ijms13089741
Article

Effects of Cyclooxygenase Inhibitors in Combination with Taxol on Expression of Cyclin D1 and Ki-67 in a Xenograft Model of Ovarian Carcinoma

* email, email, email, email and email
Received: 18 June 2012; in revised form: 22 July 2012 / Accepted: 27 July 2012 / Published: 3 August 2012
(This article belongs to the Special Issue Cancer Molecules in Ovarian Cancer 2012)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: The present study was designed to investigate the effects of cyclooxygenase (COX) inhibitors in combination with taxol on the expression of cyclin D1 and Ki-67 in human ovarian SKOV-3 carcinoma cells xenograft-bearing mice. The animals were treated with 100 mg/kg celecoxib (a COX-2 selective inhibitor) alone, 3 mg/kg SC-560 (a COX-1 selective inhibitor) alone by gavage twice a day, 20 mg/kg taxol alone by intraperitoneally (i.p.) once a week, or celecoxib/taxol, SC-560/celecoxib, SC-560/taxol or SC-560/celecoxib/taxol, for three weeks. To test the mechanism of the combination treatment, the index of cell proliferation and expression of cyclin D1 in tumor tissues were determined by immunohistochemistry. The mean tumor volume in the treated groups was significantly lower than control (p < 0.05), and in the three-drug combination group, tumor volume was reduced by 58.27% (p < 0.01); downregulated cell proliferation and cyclin D1 expression were statistically significant compared with those of the control group (both p < 0.01). This study suggests that the effects of COX selective inhibitors on the growth of tumors and decreased cell proliferation in a SKOV-3 cells mouse xenograft model were similar to taxol. The three-drug combination showing a better decreasing tendency in growth-inhibitory effect during the experiment may have been caused by suppressing cyclin D1 expression.
Keywords: ovarian carcinoma; SC-560; celecoxib; taxol; cyclin D1; cell proliferation
PDF Full-text Download PDF Full-Text [420 KB, uploaded 19 June 2014 04:23 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Li, W.; Cai, J.-H.; Zhang, J.; Tang, Y.-X.; Wan, L. Effects of Cyclooxygenase Inhibitors in Combination with Taxol on Expression of Cyclin D1 and Ki-67 in a Xenograft Model of Ovarian Carcinoma. Int. J. Mol. Sci. 2012, 13, 9741-9753.

AMA Style

Li W, Cai J-H, Zhang J, Tang Y-X, Wan L. Effects of Cyclooxygenase Inhibitors in Combination with Taxol on Expression of Cyclin D1 and Ki-67 in a Xenograft Model of Ovarian Carcinoma. International Journal of Molecular Sciences. 2012; 13(8):9741-9753.

Chicago/Turabian Style

Li, Wei; Cai, Jia-Hui; Zhang, Jun; Tang, Yun-Xian; Wan, Liang. 2012. "Effects of Cyclooxygenase Inhibitors in Combination with Taxol on Expression of Cyclin D1 and Ki-67 in a Xenograft Model of Ovarian Carcinoma." Int. J. Mol. Sci. 13, no. 8: 9741-9753.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert